A Dangerous Slope for the Future of Clinical Trials and Innovations in BioPharma

“Poor representation in clinical trials reduces our understanding of drug responses and safety for all groups.” I believe this sets the tone for where the progress of healthcare and future innovations in biotechnology are headed if more entities continue jumping on the bandwagon that intentionally imparts and weaves discrimination throughout society.